Fund Holdings — SECTORAL ASSET MANAGEMENT INC

Total Portfolio Value:
$162.01M
Total Bought:
$41.52M
Total Sold:
$51.01M
Net Transaction:
-$9.49M
Notable People:
Jerome Georges Pfund
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Contineum Therapeutics, Inc.CL A(CTNM)800,787800,7870$3.18M$9.41M5.81%+$6.23M
Eli Lilly and Company(LLY)8,9769,376+400$7.00M$7.15M4.42%+$156.8K
Structure TherapeuticsADR51,369221,872+170,503$1.07M$6.21M3.83%+$5.15M
Anaptysbio Inc83,900194,485+110,585$1.86M$5.96M3.68%+$4.09M
Shoulder Innovations, Inc.(SI)0430,282+430,282$0$5.40M3.33%+$5.40M
Arcus Biosciences, Inc.(RCUS)257,270368,070+110,800$2.09M$5.01M3.09%+$2.91M
Immatics N.V.SHS(IMTX)332,270560,494+228,224$1.79M$4.78M2.95%+$2.99M
UnitedHealth Group Incorporated(UNH)16,74513,545-3,200$5.22M$4.68M2.89%-$546.8K
Bicara Therapeutics201,395266,495+65,100$1.87M$4.21M2.60%+$2.34M
ORIC Pharmaceuticals, Inc.(ORIC)231,485328,655+97,170$2.35M$3.94M2.43%+$1.59M
Solid Biosciences421,580633,052+211,472$2.05M$3.91M2.41%+$1.85M
Kura Oncology, Inc.(KURA)323,572395,872+72,300$1.87M$3.50M2.16%+$1.64M
Ventyx Biosciences931,6201,107,267+175,647$1.99M$3.44M2.13%+$1.45M
AbbVie Inc.(ABBV)14,80014,8000$2.75M$3.43M2.12%+$679.6K
MBX Biosciences, Inc.(MBX)191,825194,898+3,073$2.19M$3.41M2.11%+$1.22M
Spdr Series TrustS P BIOTECH
ST STR SP BIOT
034,000+34,000$0$3.41M2.10%+$3.41M
Zenas BioPharma, Inc.(ZBIO)210,625152,025-58,600$2.04M$3.37M2.08%+$1.33M
Palvella Therapeutics, Inc.(PVLA)95,61549,115-46,500$2.16M$3.08M1.90%+$923.9K
Tectonic Therapeutic, Inc.(TECX)98,970192,770+93,800$1.97M$3.02M1.87%+$1.06M
Vertex Pharmaceuticals Incorporated(VRTX)6,9457,715+770$3.09M$3.02M1.86%-$70.4K
Amgen Inc.(AMGN)11,27010,340-930$3.15M$2.92M1.80%-$228.7K
Instil Bio, Inc.(TIL)86,220161,380+75,160$1.80M$2.88M1.78%+$1.09M
argenx SEADR(ARGX)4,0853,890-195$2.25M$2.87M1.77%+$617.4K
Johnson & Johnson(JNJ)19,30015,300-4,000$2.95M$2.84M1.75%-$111.1K
Intuitive Surgical, Inc.(ISRG)5,2505,750+500$2.85M$2.57M1.59%-$281.3K
BeOne Medicines AGADR(ONC)7,7167,201-515$1.87M$2.45M1.51%+$585.6K
Abbott Labs15,19817,198+2,000$2.07M$2.30M1.42%+$236.4K
Regeneron Pharmaceuticals, Inc.(REGN)2,7733,968+1,195$1.46M$2.23M1.38%+$775.3K
Gilead Sciences, Inc.(GILD)19,69019,550-140$2.18M$2.17M1.34%-$13.0K
Boston Scientific Corporation(BSX)21,12622,126+1,000$2.27M$2.16M1.33%-$109.0K
Danaher Corporation(DHR)10,57510,5750$2.09M$2.10M1.30%+$7.6K
Pfizer Inc.(PFE)77,15077,1500$1.87M$1.97M1.21%+$95.7K
Insmed Incorporated(INSM)14,88013,425-1,455$1.50M$1.93M1.19%+$435.8K
Thermo Fisher Scientific Inc.(TMO)3,9003,9000$1.58M$1.89M1.17%+$310.3K
uniQure N.V.SHS(QURE)55,45030,740-24,710$773.0K$1.79M1.11%+$1.02M
BioNTech SEADR(BNTX)16,16017,660+1,500$1.72M$1.74M1.07%+$21.1K
Stryker Corporation(SYK)3,9004,300+400$1.55M$1.59M0.98%+$46.9K
Summit Therapeutics Inc.(SMMT)65,22074,070+8,850$1.39M$1.53M0.94%+$142.4K
Alnylam Pharmaceuticals, Inc.(ALNY)3,3233,273-50$1.08M$1.49M0.92%+$408.9K
AstraZeneca PLCADR(AZN)18,64018,750+110$1.30M$1.44M0.89%+$135.9K
DexCom, Inc.(DXCM)13,20020,700+7,500$1.15M$1.39M0.86%+$240.7K
Merck & Co., Inc.(MRK)20,90016,400-4,500$1.67M$1.39M0.86%-$280.5K
BioMarin Pharmaceutical Inc.(BMRN)23,53025,030+1,500$1.29M$1.36M0.84%+$62.2K
Rapport Therapeutics, Inc.(RAPP)179,86043,480-136,380$2.05M$1.29M0.80%-$753.7K
Mineralys Therapeutics, Inc.(MLYS)382,41533,885-348,530$5.17M$1.28M0.79%-$3.89M
Syndax Pharmaceuticals, Inc.(SNDX)63,30079,430+16,130$592.8K$1.22M0.75%+$629.2K
Edwards Lifescience15,00015,0000$1.17M$1.17M0.72%-$6.6K
Tarsus Pharmaceuticals, Inc.(TARS)18,53518,405-130$750.9K$1.09M0.68%+$343.0K
Merus B V15,67511,545-4,130$824.5K$1.09M0.67%+$262.5K
Trevi Therapeutics, Inc.(TRVI)134,150105,950-28,200$733.8K$969.4K0.60%+$235.6K
Alignment Healthcare, Inc.(ALHC)054,500+54,500$0$951.0K0.59%+$951.0K
Amicus Therapeutics
COM
119,585119,105-480$685.2K$938.5K0.58%+$253.3K
Privia Health Group, Inc.(PRVA)036,500+36,500$0$908.9K0.56%+$908.9K
Vera Therapeutics, Inc.CL A(VERA)41,41830,188-11,230$975.8K$877.3K0.54%-$98.5K
Boundless Bio, Inc.(BOLD)678,574678,5740$685.4K$834.6K0.52%+$149.3K
ARS Pharmaceuticals, Inc.(SPRY)65,78581,785+16,000$1.15M$821.9K0.51%-$326.0K
RadNet, Inc.(RDNT)12,50010,000-2,500$711.4K$762.1K0.47%+$50.7K
Roivant Sciences Ltd.SHS(ROIV)50,00750,0070$563.6K$756.6K0.47%+$193.0K
ArriVent BioPharma, Inc.(AVBP)35,58039,235+3,655$774.6K$723.9K0.45%-$50.7K
Ascendis Pharma A/SADR(ASND)3,4713,601+130$599.1K$715.9K0.44%+$116.8K
BridgeBio Pharma, Inc.(BBIO)16,08513,650-2,435$694.5K$709.0K0.44%+$14.4K
Omada Health, Inc.(OMDA)34,50027,500-7,000$631.4K$608.0K0.38%-$23.3K
Ionis Pharmaceuticals, Inc.(IONS)9,2059,2050$363.7K$602.2K0.37%+$238.5K
Cytokinetics, Incorporated(CYTK)11,72310,223-1,500$387.3K$561.9K0.35%+$174.5K
Hinge Health, Inc.CL A(HNGE)9,20611,206+2,000$476.4K$550.0K0.34%+$73.6K
PTC Therapeutics, Inc.(PTCT)8,5358,5350$416.8K$523.8K0.32%+$106.9K
The Cigna Group(CI)1,8001,8000$595.0K$518.9K0.32%-$76.2K
Bristol-Myers Squibb Company(BMY)10,80010,8000$499.9K$487.1K0.30%-$12.9K
Zai Lab LimitedADR(ZLAB)15,84012,590-3,250$553.9K$426.7K0.26%-$127.3K
Neurocrine Biosciences, Inc.(NBIX)2,9602,9600$372.0K$415.5K0.26%+$43.5K
Madrigal Pharmaceuticals, Inc.(MDGL)7307300$220.9K$334.8K0.21%+$113.9K
Biogen Inc.(BIIB)2,3752,3750$298.3K$332.7K0.21%+$34.4K
Royalty Pharma plcCL A(RPRX)9,2809,2800$334.4K$327.4K0.20%-$7.0K
United Therapeutics Corporation(UTHR)7657650$219.8K$320.7K0.20%+$100.9K
Tempus AI, Inc.CL A(TEM)3,7603,7600$238.9K$303.5K0.19%+$64.6K
Jazz Pharmaceuticals plcSHS USD(JAZZ)2,2742,244-30$241.3K$295.8K0.18%+$54.4K
Illumina, Inc.(ILMN)2,7822,727-55$265.4K$259.0K0.16%-$6.4K
Incyte Corporation(INCY)6,0603,030-3,030$412.7K$257.0K0.16%-$155.7K
Vaxcyte, Inc.(PCVX)4,2054,2050$136.7K$151.5K0.09%+$14.8K
Moderna, Inc.(MRNA)5,6005,6000$154.5K$144.6K0.09%-$9.9K
Axsome Therapeutics, Inc.(AXSM)1,0201,0200$106.5K$123.9K0.08%+$17.4K
MoonLake ImmunotherapeuticsCL A(MLTX)15,108956-14,152$713.1K$6.9K0.00%-$706.2K
Caris Life Sciences, Inc.(CAI)8,3500-8,350$223.1K$0—-$223.1K
Centene Corporation(CNC)12,5000-12,500$678.5K$0—-$678.5K
CRISPR Therapeutics AGNAMEN AKT(CRSP)2,5400-2,540$123.5K$0—-$123.5K
CVRx, Inc.(CVRX)73,5000-73,500$432.2K$0—-$432.2K
Globus Medical, Inc.CL A(GMED)13,5000-13,500$796.8K$0—-$796.8K
Io Biotech Inc117,6910-117,691$163.6K$0—-$163.6K
Kestra Med TechnologSHS
SHS
35,0000-35,000$580.3K$0—-$580.3K
Legend Biotech CorporationADR(LEGN)19,6270-19,627$696.6K$0—-$696.6K
LENZ Therapeutics, Inc.(LENZ)977,2450-977,245$28.64M$0—-$28.64M
Medpace Holdings, Inc.(MEDP)5310-531$166.7K$0—-$166.7K
Recursion Pharmaceuticals, Inc.CL A(RXRX)11,5000-11,500$58.2K$0—-$58.2K
Replimune Group, Inc.(REPL)231,6500-231,650$2.15M$0—-$2.15M
Revolution Medicines, Inc.(RVMD)6,2400-6,240$229.6K$0—-$229.6K
Scholar Rock Holding Corporation(SRRK)10,3800-10,380$367.7K$0—-$367.7K
Tourmaline Bio Inc116,5100-116,510$1.86M$0—-$1.86M
Viatris Inc.(VTRS)19,8000-19,800$176.8K$0—-$176.8K
Page 1 of 1
SECTORAL ASSET MANAGEMENT INC — 13F Holdings — Q3 2025 | TickerTrail